An Internet-based Psychosexual Intervention for Couples Following Treatment for Breast Cancer (IPSIC)

February 21, 2019 updated by: Karen Fergus, Sunnybrook Health Sciences Centre

An Evaluation of an Internet-based, Psychosexual Intervention for Couples Following Treatment for Breast Cancer: A Phase I Trial

Diagnosis and treatment of breast cancer often leads to lower levels of sexual desire, decreased sexual arousal, painful intercourse, and difficulties achieving orgasm, and thus adversely impacts sexual functioning and intimacy. Despite the overwhelming evidence that many couples experience sexual distress following breast cancer, very few interventions have been designed exclusively to address these concerns. The purpose of this study is to develop and evaluate an online psychosexual program geared to the unique needs of couples experiencing sexual distress after breast cancer. This study will utilize a web-based approach, allowing couples to participate in the program from the privacy and comfort of their homes, and providing a resource to couples who may not otherwise be able to readily access support. Accordingly, this project has the potential for widespread positive impact for couples affected by breast cancer.

Study Overview

Status

Completed

Conditions

Detailed Description

Many couples experience sexual problems following breast cancer treatment, and difficulties with intimacy and sexuality tend to extend past the 1 year post-treatment point. Given that resources available for couples who experience sexual distress after breast cancer are virtually non-existent, there is a need to develop and empirically evaluate psychosexual interventions for breast cancer patients and their partners.

The purpose of this study is to evaluate the feasibility, process, and outcomes of an online, couples-based intervention designed to address sexual problems encountered by many couples facing breast cancer. The intervention will take place in the form of six E-therapy sessions delivered via secure, encrypted videoconferencing software commonly used by health care providers practicing telemedicine. Each session will be supplemented by psychoeducational materials (i.e. reading and/or video) available through a privately accessed homepage for the study.

Thirty couples will participate in the study, and will be be randomized to either the treatment condition or the wait-list control condition. Participants assigned to the wait-list will have the option of receiving the online program once they have completed their commitment to the study (approximately 5 months later). In addition to completing standardized questionnaires, couples will participate in pre- and post-treatment interviews, which will be analyzed thematically in order to improve the intervention and its delivery.

The proposed project builds upon existing research pertaining to the sexual health implications of female cancer survivorship, and will fill a gap both in the literature and support available to breast cancer survivors experiencing sexual distress. Given that sexual distress is such a crucial concern for women with breast cancer, and that the majority of couples experiencing sexual difficulties may not receive adequate support in this regard, the goal of the proposed project will be the creation of an accessible, cost-effective, empirically validated tool that could help improve the quality of life of couples affected by breast cancer.

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M4N 3M5
        • Sunnbrook Odette Cancer Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 80 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

-Patient has received a diagnosis within the last 5 years of invasive breast carcinoma (non- metastatic), or ductal carcinoma in-situ

  • Patient has received a mastectomy or lumpectomy and undergone adjuvant therapy (i.e.

chemotherapy, radiation, tamoxifen)

  • Patient is at least 1 month post-treatment.
  • Couples are in a committed relationship of at least 3 months duration at the time of diagnosis
  • Participants must be fluent in English
  • Participants must be 80 years of age or younger
  • Participants will require convenient access to a computer with a reliable internet connection in a private setting and have access to videoconferencing software (available for download at no cost).

Exclusion Criteria:

  • One or both of the partners are currently struggling with any mental illness that would interfere with the ability to participate (e.g. actively suicidal; currently psychotic
  • Couples who plan to participate in couples or sex counselling during the study
  • Couples experiencing significant levels of relationship distress (e.g. presence of violence or abuse), in which case they will be referred for couple counseling

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Psychosexual Intervention
The intervention will consist of 6 weekly sessions of couples psychosexual counseling delivered via videoconferencing.
Couples will complete six weekly psychosexual counselling sessions. Each session will focus on areas relevant to sex therapy and sexual dysfunction in couples facing breast cancer (e.g. education, communication, body imagery, sensate focusing, and problem solving). Sessions will be one hour in length (Note: Session 1 will be 1.5 hours), during which couples will meet with a facilitator via videoconferencing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Sexual Function Questionnaire for Men and Women (SFQ-W, SFW-M) scores from pre (0 weeks) to post-treatment (6 weeks), and 3 month follow-up
Time Frame: pre-treatment (0 weeks), immediate post-treatment (6 weeks), and 3 month follow-up
The SFQ assesses couples' sexual satisfaction and functioning. The SFQ will be used to assess change in couples' level of sexual functioning.
pre-treatment (0 weeks), immediate post-treatment (6 weeks), and 3 month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Revised Dyadic Adjustment Scale (RDAS)
Time Frame: pre-treatment (0 weeks), immediate post-treatment (6 weeks), and 3 month follow-up
The RDAS assesses couple's level of relationship satisfaction.
pre-treatment (0 weeks), immediate post-treatment (6 weeks), and 3 month follow-up
Maudsley Marital Questionnaire (marital sub-scale only)
Time Frame: pre-treatment (0 weeks), immediate post-treatment (6 weeks), and 3 month follow-up
The Maudsley Marital Questionnaire assesses martial quality and happiness.
pre-treatment (0 weeks), immediate post-treatment (6 weeks), and 3 month follow-up
Profile of Mood States Short Form (POMS-SF)
Time Frame: pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up
The POMS-SF assesses overall psychological adjustment.
pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up
Centre for Epidemiological Studies Depression Scale
Time Frame: pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up
This measure assesses psychological adjustment, specifically with respect to depressive symptoms.
pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up
Generalized Anxiety Disorder Assessment (GAD-7)
Time Frame: pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up
This measure assesses psychological adjustment, specifically with respect to anxiety
pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up
Breast Cancer Prevention Trial Symptom Checklist
Time Frame: pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up
The BCPT measures commonly reported physical and psychological symptoms associated with breast cancer and associated treatments.
pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up
Spousal Skills Checklist
Time Frame: pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up
The SSC measures partners' perceived support of their female partners
pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Program Expectancy Questionnaire
Time Frame: Pre-treatment (0 weeks)
The Program Expectancy Questionnaire will assess participants' expectations for the intervention, including the degree to which they believe the intervention will be effective.
Pre-treatment (0 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karen Fergus, PhD, Toronto Sunnybrook Regional Cancer Centre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2015

Primary Completion (Actual)

September 1, 2017

Study Completion (Actual)

September 1, 2017

Study Registration Dates

First Submitted

June 14, 2013

First Submitted That Met QC Criteria

June 14, 2013

First Posted (Estimate)

June 19, 2013

Study Record Updates

Last Update Posted (Actual)

February 25, 2019

Last Update Submitted That Met QC Criteria

February 21, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on Psychosexual Intervention

3
Subscribe